HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection

Diabetes

Volumn 46, Issue 1, 1997, Pages 143-149

  Undlien, Dag E ^a   Friede, Thomas ^d   Rammensee, Hans Georg ^d   Joner, Geir ^b   Dahl Jørgensen, Knut ^b   Søvik, Oddmund ^c   Akselsen, Hanne E ^a   Knutsen, Ingebjørg ^a   Rønningen, Kjersti S ^a   Thorsby, Erik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031024575     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.143     Document Type: Article

References (38)

1. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
2. Singal DP, Blajchman MA: Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22:429-432, 1973
3. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A: HL-A antigens and diabetes mellitus. Lancet ii:864-866, 1974
4. Nerup J, Seignalet J, Thomsen M: HLA and endocrine diseases. In HLA and Disease. Dausset J, Svejgaard A, Eds. Copenhagen, Munksgaard, 1977, p. 149-167
5. Solow H, Hidalgo R, Singal DP: Juvenile-onset diabetes HLA-A, -B, -C, and -DR alloantigens. Diabetes 28:1-4, 1979
6. Fand NR, Sampson L, Noel P Barnard JM, Davis AJ, Hillman DA: HLA-D-related (DRw) antigens in juvenile diabetes mellitus. Diabetes 28:552-557, 1979
7. Owerbach D, Lernmark Å, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigsson J: HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303:815-817, 1983
8. Thorsby E: HLA-associated disease susceptibility: which genes are primarily involved? Immunologist 3:51-58, 1995
9. Thorsby E, Rønningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377, 1993
10. Raum D, Awdeh Z, Yunis EJ, Alper CA, Gabbay KH: Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest 74:449-454, 1984
11. Robinson WP, Barbosa J, Rich SS, Thomson G: Homozygous parent affected sib pair method for detecting disease predisposing variants: application to insulin dependent diabetes mellitus. Genet Epidemiol 10:273-288, 1993
12. Sheehy MJ, Scharf SJ, Rowe JR, Neme de Gimenez MH, Meske LM, Erlich HA, Nepom BS: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 83:830-835, 1989
13. Rønningen KS, Spurkland A, Tait BD, Drummond BP, Lopez-Larrea C, Baranda FS, Menendez-Diaz J, Caillat-Zucman S, Beaurain G, Garchon HJ, Ilonen J, Reijonen H, Knip M, Boehm O, Rosak C, Loliger C, Kuhnl P, Ottenhoff T, Contu L, Carcassi C, Savi M, Zanelli P, Neri TM, Hamaguchi K, Kimura A, Dong RP, Chikuba N, Nagataki S, Gorodezky C, Debaz H, Robles C, Coimbra HB, Martinho A, Ruas MA, Sachs JA, Garcia-Pachedo M, Biro A, Nikaein A, Dombrausky L, GonwaT, Zmijewski C, Monos D, Kamoun M, Layrisse Z, Magli MC, Balducci P, Thorsby E: HLA class II associations in insulin-dependent diabetes mellitus among blacks, Caucasoids and Japanese. In HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Tsuji K, Aizawa M, Sasazuki T, Eds. Oxford, Oxford University Press, 1993, p. 713-722
14. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougneres P, Bach JF: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250, 1992
15. Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, Beshkov Y, Costin G, Pressman S, Bugawan T, Rotter JI: HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 3:358-364, 1993
16. Cucca F, Lampis R, Frau F, Macis D, Angius E, Masile P, Chessa M, Frongia P, Silvetti M, Can A, De Virgiliis S, Congia M: The distribution of DR4 haplotypes in Sardinia suggests a primary association of type 1 diabetes with DRB1 and DQB1 loci. Hum Immunol 43:301-308, 1995
17. Van der Auwera B, Van Waeyenberge C, Schuit F, Heimberg H, Vandewalle C, Gorus F, Flament J: DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype: Belgian Diabetes Registry. Diabetes 44:527-530, 1995
18. Yasunaga S, Kimura A, Hamaguchi K, Rønningen KS, Sasazuki T: Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47:37-48, 1996
19. Rønningen KS, Spurkland A, Markussen G, Iwe T, Vartdal F, Thorsby E: Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol 29:275-281, 1990
20. Rønningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E: Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 37:105-111, 1991
21. Heiland Å, Børresen AL, Kristensen G, Rønningen KS: DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis. Cancer Epidemiol Biomarkers Prev 3:479-486, 1994
22. Spurkland A, Knutsen I, Markussen G, Vartdal F, Egeland T, Thorsby E: HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support. Tissue Antigens 41:155-164, 1993
23. Tiwari JL, Terasaki P: The data and statistical analysis. In HLA and Disease Associations. Tiwari JL, Terasaki P, Eds. Berlin, Springer-Verlag, 1985, p. 18-27
24. Neutra RE, Drolette ME: Estimating exposure-specific disease rates from case-control studies using Bayes' theorem. Am J Epidemiol 108:214-222, 1978
25. Joner G, Søvik O: Increasing incidence of diabetes mellitus in Norwegian children 0-14 years of age 1973-1982. Diabetologia 32:79-83, 1989
26. Rowe JR, Mickelson EM, Hansen JA, MacDonald MJ, Allen CI, Gabbay KH, Yunis EJ, Sheehy MJ: T-cell-defined DR4 subtypes as markers for type 1 diabetes. Hum Immunol 22:51-60, 1988
27. Monos DS, Mickelson E, Hansen JA, Baker L, Zmijewski CM, Kamoun M: Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus. Hum Immunol 23:289-299, 1988
28. Åkerblom HK, Savilahti E, Saukkonen TT, Paganus A, Virtanen SM, Teramo K, Knip M, Ilonen J, Reijonen H, Karjalainen J, Vaarala O, Reunanen A: The case for elimination of cow's milk in early infancy in the prevention of type 1 diabetes: the Finnish experience. Diabetes Metab Rev 9:269-278, 1993
29. Wucherpfennig KW, Strominger JL: Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 181:1597-1601, 1995
30. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F: Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181:1847-1855, 1995
31. Wucherpfennig KW, Yu B, Bhol K, Monos D, Argyris E, Karr RW, Ahmed AR, Strominger JL: Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 92:11935-11939, 1996
32. Friede T, Gnau V, Jung G, Keilholz W, Stevanovic S, Rammensee HG: Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochim Biophys Acta 1316:85-101, 1996
33. Rammensee HG, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228, 1995
34. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F: Precise prediction of major histocompatibility complex class D-peptide interaction based on peptide side chain scanning. J Exp Med 180:2353-2358, 1994
35. Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y: Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180:873-883, 1994
36. Kinouchi R, Kobayasi H, Sato K, Kimura S, Katagiri M: Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules. Immunogenetics 40:376-378, 1994
37. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG: Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39:230-242, 1994
38. Sheehy MJ: HLA and insulin-dependent diabetes: a protective perspective. Diabetes 41:123-129, 1992